Caeli Nova

📍 London, United Kingdom🗓 Founded 2018👥 31 employees💰 Last funded Jan 2022
Aviation and Aerospace Component Manufacturing🌐 caelinova.com
Website LinkedIn
Caeli Nova’s patented breathing technology improves oxygenation of the human body in demanding situations such as altitude. Caeli Nova’s award-winning product, Cordillera, is an emergency oxygen system suitable for commercial and military passenger aircraft. This key safety system is designed to protect passengers in the rare event of a loss of cabin pressure, while removing most operational constraints and limitations faced by airlines, airframers and defence aerospace today. Cordillera allows airlines to operate shorter flights, with associated reductions in fuel and carbon emissions, and to reduce the fuel reserves needed to be carried on ETOPS flights.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in Caeli Nova?
Caeli Nova has 1 investors on record on gritt.io, 1 mid-stage.
When did Caeli Nova last raise funding?
The most recent investment in Caeli Nova recorded on gritt.io was in January 2022.
When was Caeli Nova founded?
Caeli Nova was founded in 2018.
What industry is Caeli Nova in?
Caeli Nova operates in Aviation and Aerospace Component Manufacturing. Find similar Aviation and Aerospace Component Manufacturing investors on gritt.io.
Where is Caeli Nova based?
Caeli Nova is headquartered in London, United Kingdom.